Gsa Capital Partners LLP Astrazeneca PLC Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$66.81 - $80.83 $325,431 - $393,722	4,871 New	4,871 $380,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $262,403 - $315,007	-4,428 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $246,728 - $297,207	4,428 New	4,428 $294,000
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $358,744 - $426,336	-8,449 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $338,973 - $384,176	8,449 New	8,449 $377,000

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.